Global Musculoskeletal Disorders Therapeutics Market 2016-2020
- Published: Aug 2016
- Pages: 120
- SKU: IRTNTR10170
Enjoy complimentary customisation on priority with our Enterprise License!
Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
This market report classifies vendors such as AbbVie, Johnson & Johnson, Amgen, Pfizer, F. Hoffmann-La Roche, and Eli Lilly as the key players in this market space. This report also segments the market by disease type (rheumatoid arthritis, osteoarthritis, osteoporosis, psoriatic arthritis, ankylosing spondylitis, and fibromyalgia), by type of molecule (biologics and small molecules), by route of administration (parenteral, topical, and oral), and by geography (the Americas, APAC, and EMEA).
Global musculoskeletal disorders therapeutics market outlook
The analyst at Technavio predicts that the global musculoskeletal disorders therapeutics market will grow progressively and will post a modest CAGR of approximately 4% by 2020. One of the major factors that will drive market growth is the growing unmet medical needs in the global musculoskeletal disorders market. The unavailability of a cure for psoriatic arthritis will induce researchers to develop drugs that increase bone density, replace lost bone, and rebuild bone strength. Furthermore, to gain a competitive advantage, vendors will have to develop cost-competitive drugs with ease of administration that promotes bone building efficiently. For instance, Pfizer recently launched bazedoxifene and obtained US FDA approval for bazedoxifene as part of the combination drug Duavee in the prevention of postmenopausal osteoporosis. The lack of proper treatments and biologic drugs with severe side-effects will create an opportunity for vendors to develop therapies that have better efficacy and safety profiles.
According to the musculoskeletal disorders therapeutics market forecast, the Americas will dominate the market accounting for approximately 52% of the total market share. Higher uptake of existing biologic drugs to treat the condition, the launch of new biologics, and expanded access to medical care due to healthcare issues are factors that will drive the prospects for market growth. In addition, essential health-care benefits provided by employer-sponsored health insurance plans and increasing vendor investments in innovative and cost-effective drugs will also help the Americas to lead the market during the forecast period.
Competitive landscape and key vendors
There is intense competition in the market and few key vendors lead the market with innovative product launches that counter the side-effects of biologic drugs, partnerships that help the research and developments of new medicines, and merger and acquisitions to introduce cost-effective drugs that have a wider customer reach.
Key vendors in the market are
- AbbVie
- Johnson & Johnson
- Amgen
- Pfizer
- F. Hoffmann-La Roche
- Eli Lilly
Other prominent vendors in the market are 3SBio, AB Sciences, AbGenomics International, Ablynx, Adheron, Akron Molecules, Alder BioPharmaceuticals, Amgen Astellas BioPharma, Ampio Pharmaceuticals, Antares Medical Services, Astellas, AstraZeneca, Baxter, Biocad, Bioiberica, Boehringer Ingelheim, Bone Therapeutics, Can-Fite BioPharma, Celgene Corporation, Celltrion, Cellular Biomedicine, Cerapedics, ChemoCentryx, Chugai Pharmaceutical, Coherus Biosciences, Daiichi Sankyo, Dong-A ST, Edding Pharm, Eisai, Epirus, Eupraxia Pharmaceuticals, Flexion Therapeutics, Galapagos NV, Gedeon Richter, Gilead Sciences, GlaxoSmithKline, Histogenics, IBSA Institut Biochimique, iCeutica, Iltoo Pharma, Incyte Corporation, Innovative Med Concepts, Iroko Pharmaceuticals, ISTO Technologies, KaloBios Pharmaceuticals, KAN Research Institute, Kang Stem Biotech, Kitov Pharmaceuticals, Lexicon Pharmaceuticals, LG Life Sciences, MEDIPOST, Medivir, Merck, Mereo, Mesoblast, MOCHIDA PHARMACEUTICAL, MorphoSys, Morphotek, Mycenax, Neomed Institute, Novartis, Omeros Corporation, OrthoTrophix, Osteologix, OxyPharma, PFEnex, Philogen, PhytoHealth Corporation, Plexxikon, PLx Pharma, Protalex, Proximagen Limited, Radius Health, Regeneron Pharmaceuticals, Samsung Bioepis, Samumed, Sandoz, Sanofi, SantoSolve AS, Steminent Biotherapeutics, Stempeutics Research, Taisho Pharmaceutical, Taiwan Liposome Company, Takeda, Tarsa Therapeutics, Techfields Pharma, Tetec , TheraMAB, TiGenix, TissueGene, Tonix Pharmaceuticals, Translational Biosciences, UCB, Vericel, Vertex Pharmaceuticals, Vitaeris, Winston Laboratories, and Zosano Pharma Corporation.
Segmentation based on the type of disease and analysis of the global musculoskeletal disorders therapeutics market
- Rheumatoid arthritis
- Osteoarthritis
- Osteoporosis
- Psoriatic arthritis
- Ankylosing spondylitis
- Fibromyalgia
During 2015, rheumatoid arthritis dominated the market by accounting for approximately 52% of the total market share. It is a chronic inflammatory autoimmune disease, and the symptoms appear slowly with mild pain around the joints coupled with stiffness and fatigue. This condition is most common in people within the age group of 30 to 60 years.
Segmentation based on the type of molecule and analysis of the global musculoskeletal disorders therapeutics market
- Biologics
- Small molecules
During 2015, the biologics molecule segment dominated the market, accounting for around 82% of the total market share. Biologics have a complex structure that does not allow easy identification or characterization and are mostly thermo-labile and susceptible to microbial contamination.
Key questions answered in the report include
- What will the market size and the growth rate be in 2020?
- What are the key factors driving the global musculoskeletal disorders therapeutics market?
- What are the key market trends impacting the global musculoskeletal disorders therapeutics market?
- What are the challenges to market growth?
- Who are the key vendors in the global musculoskeletal disorders therapeutics market?
- What are the market opportunities and threats faced by the vendors in the global musculoskeletal disorders therapeutics market?
- Trending factors influencing the market shares of the Americas, APAC, and EMEA.
- What are the key outcomes of the five forces analysis of the global musculoskeletal disorders therapeutics market?
Technavio also offers customization on reports based on specific client requirement.
Related reports
- Global Anxiety Disorders Market 2015-2019
- Global Biologic Therapeutics Market 2015-2019
- Global Bipolar Disorder Therapeutics Market 2015-2019
Table of Contents
PART 01: Executive summary
- Highlights
PART 02: Scope of the report
- Market overview
- Top-vendor offerings
PART 03: Market research methodology
- Research methodology
- Economic indicators
PART 04: Introduction
- Key market highlights
PART 05: Pipeline portfolio
PART 06: Market landscape
- Market overview
- Market size and forecast
- Five forces analysis
PART 07: Market segmentation by disease type
- Rheumatoid arthritis
- Osteoarthritis
- Osteoporosis
- Psoriatic arthritis
- Ankylosing spondylitis
- Fibromyalgia
PART 08: Global rheumatoid arthritis drugs market
- Market overview
PART 09: Global osteoarthritis drugs market
- Market overview
PART 10: Global osteoporosis drugs market
- Market overview
PART 11: Global ankylosing spondylitis drugs market
- Market overview
PART 12: Global psoriatic arthritis drugs market
- Market overview
PART 13: Global fibromyalgia drugs market
- Market overview
PART 14: Market segmentation by type of molecule
- Biologics
- Small molecules
PART 15: Market segmentation by route of administration
- Parenteral
- Topical
- Oral
PART 16: Geographical segmentation
- Global musculoskeletal disorder therapeutics market by geography 2015-2020
- Musculoskeletal disorders therapeutics market in Americas
- Musculoskeletal disorders therapeutics market in EMEA
- Musculoskeletal disorders therapeutics market in APAC
PART 17: Market drivers
- High growth potential of mAbs
- Unmet needs of therapeutics
- Tentative approval of advanced drugs
- Technological advancements in medical imaging
- Combination therapies
PART 18: Impact of drivers
PART 19: Market challenges
- Non-adherence to treatment regimen
- Growing preference toward surgeries
- Multiple patent expiries
PART 20: Impact of drivers and challenges
PART 21: Market trends
- Focus on regenerative medicines
- Ongoing active clinical trials for biosimilars
- Growing focus toward abuse-resistant novel drugs
PART 22: Vendor landscape
- Competitive scenario
PART 23: Key vendor analysis
- AbbVie
- Johnson & Johnson
- Amgen
- Pfizer
- F. Hoffmann-La Roche
- Eli Lilly
- Other prominent vendors
PART 24: Appendix
- List of abbreviations
PART 25: Explore Technavio
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases

DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts

REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
Certified ISO 9001 : 2015

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
2500 USD
Get the report (PDF) sent to your email within minutes.
Subscribe & Save
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
- Our analysts will work directly with you and understand your needs
- Get data on specified regions or segments, competitor and Vendors
- Data will be formatted and presented as per your requirements
- We offer $1000 worth of FREE customization at the time of purchase
Let us help you make report more suited to your requirements.
- Get a competitive breakdown as per your niche industry
- Customize the data with various metrics that meet your business prerequisite
- Understand Revenue Sources, Customers and many more
- Details on Market Share
- These customizations are done in a short amount of time by our analysts and industry experts
